Fusion Antibodies has announced the appointment of an interim Chief Financial Officer (CFO). The company has not provided any specific details about the individual who will be taking on this role. The announcement can be viewed in full on the Fusion Antibodies website.

The company has not provided any additional information or context regarding the appointment of the interim CFO. It is unclear whether this appointment is temporary or if the company is actively searching for a permanent CFO.

For any inquiries or questions about Fusion Antibodies, interested parties are advised to contact Walbrook PR, either by phone or email. The provided contact information is 020 7933 8780 and [email protected].

The email also includes a link for subscribers to remove their name from the Fusion Antibodies News Alert Service. By visiting the provided link, subscribers can enter their name and email address, select the "Unsubscribe" option, and submit the form to be removed from the mailing list.

The email concludes with a privacy statement and a reminder that the email address used to send the message is not monitored for replies.